EVIDÊNCIAS DO TRATAMENTO E DA PROFILAXIA DA PRÉ-ECLÂMPSIA NA GESTAÇÃO
PDF (Português (Brasil))

Keywords

Pré-eclâmpsia
Eclâmpsia
Prevenção
Tratamento

How to Cite

Gonçalves, A. W. O., Castro, M. P. B. de, Camargo, T. F., Silva, G. M. da, Sousa, C. M. de, Sarah, R. de L., Pereira, I. F. C., Sarah, R. M., Mesquita, N. P. de, Lima, R. do V., Silva, A. C. M. da, & Lima, P. B. (2024). EVIDÊNCIAS DO TRATAMENTO E DA PROFILAXIA DA PRÉ-ECLÂMPSIA NA GESTAÇÃO. Brazilian Journal of Implantology and Health Sciences, 6(10), 402–422. https://doi.org/10.36557/2674-8169.2024v6n10p402-422

Abstract

Introduction: Preeclampsia is a multifactorial and multisystemic disease specific to pregnancy. It is classically diagnosed by the presence of arterial hypertension associated with proteinuria in a previously normotensive pregnant woman after the 20th week of gestation. Objective: To gather updated evidence on the treatment and prophylaxis of preeclampsia. Methodology: This is a literature review, with a qualitative, descriptive, exploratory and explanatory approach. In addition, because it is a literature review, it also has a bibliographic approach. As this is a literature review, a search was carried out in the Google Scholar and PubMed databases, between the years 2018 to 2024, using the following keywords: “preeclampsia”, “eclampsia”, “prevention”, “treatment” combined with the AND and OR operators. Results and Discussion: When conducting searches in PubMed, the search registered 171 articles, of which 158 were excluded based on the title and abstract, while in Google Scholar, 130 publications were registered, of which 123 were excluded based on the same criteria, in addition, they presented deviations from the topic and/or addressed a perspective different from that projected by the work. Therefore, 20 studies satisfied the proposal of the present review. Management is based on general principles, on the non-pharmacological and pharmacological clinical treatment of serious or non-serious situations with emphasis on pre-eclampsia, eclampsia and hypertensive crisis. Prevention of pre-eclampsia is the best way to avoid unfavorable outcomes during pregnancy. Aspirin is universally recommended for high-risk women to reduce the risk of pre-eclampsia. The recommended dose and gestational age at onset vary. Magnesium sulfate is the first-choice medication, which aims to stop eclampsia seizures and prevent recurrence of seizures and complications, while antihypertensives are for adequate control of blood pressure in order to effectively reduce the risk of death or acute complications and poor pregnancy outcomes. The most urgent part of the treatment is the life-saving procedure. Conclusion: Preeclampsia is a serious condition that can affect pregnant women in the 20th week of pregnancy, therefore, prenatal care accompanied by a doctor is essential, especially if the pregnancy is high-risk, and referral to an obstetrician is necessary.

                                                                                                                

Keywords: Preeclampsia. Eclampsia. Prevention. Treatment.

https://doi.org/10.36557/2674-8169.2024v6n10p402-422
PDF (Português (Brasil))

References

REFERÊNCIAS

BROWNFOOT, F.; ROLNIK, D. L. Prevention of preeclampsia. Best Pract Res Clin Obstet Gynaecol. 2024 Mar;93:102481. doi: 10.1016/j.bpobgyn.2024.102481. Epub 2024 Feb 15. PMID: 38373378. Disponível em:https://pubmed.ncbi.nlm.nih.gov/38373378/. Acesso em: 18 de ago. de 2024.

CAMPOS, N. L. R. et al. Percalços na detecção precoce da pré-eclâmpsia durante pré-natal na Atenção Primária à Saúde. Scientific Electronic Archives, Vol. 16 (12). 2023. Disponível em:https://sea.ufr.edu.br/index.php/SEA/article/view/1812/1902. Acesso em: 21 de ago. de 2024.

COLAFELLA, K. M. M. et al. Aspirin for the prevention and treatment of pre-eclampsia: A matter of COX-1 and/or COX-2 inhibition? Basic Clin Pharmacol Toxicol. 2020 Aug;127(2):132-141. doi: 10.1111/bcpt.13308. Epub 2019 Sep 11. PMID: 31420920; PMCID: PMC7496715. Disponível em:https://pubmed.ncbi.nlm.nih.gov/31420920/. Acesso em: 29 de ago. de 2024.

DULEY, L. et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2019 Oct 30;2019(10):CD004659. doi: 10.1002/14651858.CD004659.pub3. PMID: 31684684; PMCID: PMC6820858. Disponível em:https://pubmed.ncbi.nlm.nih.gov/31684684/. Acesso em: 15 de ago. de 2024.

FEBRASGO. Pré-eclâmpsia nos seus diversos aspectos. - São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO), 2017. Série Orientações e Recomendações FEBRASGO. n. 8, 2017. Disponível em:https://www.febrasgo.org.br/media/k2/attachments/12-PRE_ECLAyMPSIA.pdf. Acesso em: 16 de ago. de 2024.

FILIPEK, A.; JUREWICZ, E. Preeklampsja – choroba kobiet w ciąży [Preeclampsia - a disease of pregnant women]. Postepy Biochem. 2018 Dec 29;64(4):232-229. Polish. doi: 10.18388/pb.2018_146. PMID: 30656917. Disponível em:https://pubmed.ncbi.nlm.nih.gov/30656917/. Acesso em: 23 de jul. de 2024.

HONIGBERG, M. C. et al. Polygenic prediction of preeclampsia and gestational hypertension. Nat Med. 2023 Jun;29(6):1540-1549. doi: 10.1038/s41591-023-02374-9. Epub 2023 May 29. PMID: 37248299; PMCID: PMC10330886. Disponível em:https://pubmed.ncbi.nlm.nih.gov/37248299/. Acesso em: 19 de ago. de 2024.

HOFMEYR, G. J. et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2018 Oct 1;10(10):CD001059. doi: 10.1002/14651858.CD001059.pub5. PMID: 30277579; PMCID: PMC6517256. Disponível em:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517256/. Acesso em: 18 de ago. de 2024.

HURRELL, A. et al. Recent advances in the diagnosis and management of pre-eclampsia. Fac Rev. 2020 Nov 16;9:10. doi: 10.12703/b/9-10. PMID: 33659942; PMCID: PMC7886065. Disponível em:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886065/. Acesso em: 19 de ago. de 2024.

LU, Y. et al. The management of hypertension in women planning for pregnancy. Br Med Bull. 2018 Dec 1;128(1):75-84. doi: 10.1093/bmb/ldy035. PMID: 30371746; PMCID: PMC6289217. Disponível em:https://pubmed.ncbi.nlm.nih.gov/30371746/. Acesso em: 19 de ago. de 2024.

IVES, C. W. et al. Pre-eclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 Oct 6;76(14):1690-1702. doi: 10.1016/j.jacc.2020.08.014. PMID: 33004135. Disponível em:https://pubmed.ncbi.nlm.nih.gov/33004135/. Acesso em: 20 de jul. de 2024.

MA’AYEH, M.; CONSTANTINE, M. M. Prevention of preeclampsia. Semin Fetal Neonatal Med. 2020 Oct;25(5):101123. doi: 10.1016/j.siny.2020.101123. Epub 2020 Jun 2. PMID: 32513597; PMCID: PMC8236336. Disponível em:https://pubmed.ncbi.nlm.nih.gov/32513597/. Acesso em: 23 de jul. de 2024.

MARTIN, J. F. V. et al. Posicionamento Luso-Brasileiro de Emergências Hipertensivas. Arquivos Brasileiros De Cardiologia, 114(4), 2020, 736–751. https://doi.org/10.36660/abc.20190731. Disponível em:https://pesquisa.bvsalud.org/brasil/resource/pt/biblio-1147643. Acesso em: 18 de ago. de 2024.

PERAÇOLI, J. C. et al. Pre-eclampsia/Eclampsia. Rev Bras Ginecol Obstet. 2019 May;41(5):318-332. English. doi: 10.1055/s-0039-1687859. Epub 2019 Jun 10. Erratum in: Rev Bras Ginecol Obstet. 2019 May;41(5):e1-e2. doi: 10.1055/s-0040-1702167. PMID: 31181585. Disponível em:https://pubmed.ncbi.nlm.nih.gov/31181585/. Acesso em: 20 de jul. de 2024.

PERAÇOLI, J. C. et al. Pré-eclâmpsia/eclâmpsia – Protocolo no. 01 - Rede Brasileira de Estudos sobre Hipertensão e Gravidez (RBEHG), 2020. Disponível em:https://www.cemicamp.org.br/wp-content/uploads/2022/04/PRE_ECLAMPSIA_ECLAMPSIA_PROTOCOLO_RBEHG_2020_.pdf. Acesso em: 21 de ago. de 2024.

PRADO, C. A. P. et al. Diretriz clínica para prevenção, diagnóstico e manejo de síndromes hipertensivas na gestação. Projeto Todas as Mães importam, DA SBIB ALBERT EINSTEIN E MSD PARA MÃES (2023). Disponível em:https://www.einstein.br/DocumentosAcessoLivre/DIRETRIZ-CLINICA-PARA-PREVENCAO-DIAGNOSTICO-E-MANEJO-DE-SINDROMES-HIPERTENSIVAS-NA-GESTACAO-TMI.pdf. Acesso em: 19 de ago. de 2024.

RAHNEMAEI, F. A.; FASHAMI, M. A.; ABDI, F. et al. Factors effective in the prevention of Preeclampsia:A systematic review. Taiwan J Obstet Gynecol. 2020 Mar;59(2):173-182. doi: 10.1016/j.tjog.2020.01.002. PMID: 32127134. Disponível em:https://pubmed.ncbi.nlm.nih.gov/32127134/. Acesso em: 18 de ago. de 2024.

SAKOWICZ, A. et al. New Ideas for the Prevention and Treatment of Preeclampsia and Their Molecular Inspirations. Int J Mol Sci. 2023 Jul 28;24(15):12100. doi: 10.3390/ijms241512100. PMID: 37569476; PMCID: PMC10418829. Disponível em:https://pubmed.ncbi.nlm.nih.gov/37569476/. Acesso em: 17 de ago. de 2024.

SOUSA, V. P. et al. Atenção farmacêutica à gestantes portadoras de pré-eclâmpsia. Revista Saúde.com, [S. l.], v. 17, n. 4, 2021. DOI: 10.22481/rsc.v17i4.4935. Disponível em: https://periodicos2.uesb.br/index.php/rsc/article/view/4935. Acesso em: 21 ago. 2024.

TOLEDO, L. L. Marcadores clínicos e laboratoriais como preditores de eventos adversos maternos e neonatais em pacientes com diagnóstico de pré-eclâmpsia precoce com critérios de gravidade. Universidade Federal de Minas Gerais. Faculdade de Medicina. Programa de Pós-graduação em Saúde da Mulher. Belo Horizonte, 2020. Disponível em:https://pesquisa.bvsalud.org/brasil/resource/pt/biblio-1436322. Acesso em: 19 de ago. de 2024.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Antonio Walberto Oliveira Gonçalves, Micheli Poliana Beltramin de Castro, Thaynara Fernandes Camargo, Glauco Martins da Silva, Clévia Maria de Sousa, Ronierisson de Lima Sarah, Isau Flávio Coutinho Pereira, Rair Magalhães Sarah, Nailson Pereira de Mesquita, Rayza do Vale Lima, Ana Caroline Martins da Silva, Priscila Barbosa Lima